Page last updated: 2024-09-04

3,3',4'-trihydroxyflavone and beta-escin

3,3',4'-trihydroxyflavone has been researched along with beta-escin in 1 studies

Compound Research Comparison

Studies (3,3',4'-trihydroxyflavone)	Trials (3,3',4'-trihydroxyflavone)	Recent Studies (post-2010) (3,3',4'-trihydroxyflavone)	Studies (beta-escin)	Trials (beta-escin)	Recent Studies (post-2010) (beta-escin)
39	0	22	580	72	148

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kim, HY; Kim, IK; Seok, YM; Williams, SJ; Woodman, OL	1

Other Studies

1 other study(ies) available for 3,3',4'-trihydroxyflavone and beta-escin

Article	Year
3',4'-Dihydroxyflavonol reduces vascular contraction through Ca²⁺ desensitization in permeabilized rat mesenteric artery. Naunyn-Schmiedeberg's archives of pharmacology, 2012, Volume: 385, Issue:2 Topics: Animals; Calcium; Cardiovascular Agents; Escin; Flavonols; Guanosine 5'-O-(3-Thiotriphosphate); In Vitro Techniques; Male; Mesenteric Arteries; Permeability; Phenylephrine; Rats; Rats, Sprague-Dawley; Sodium Fluoride; Vasoconstriction	2012

Article

Year

3',4'-Dihydroxyflavonol reduces vascular contraction through Ca²⁺ desensitization in permeabilized rat mesenteric artery.

Naunyn-Schmiedeberg's archives of pharmacology, 2012, Volume: 385, Issue:2

Topics: Animals; Calcium; Cardiovascular Agents; Escin; Flavonols; Guanosine 5'-O-(3-Thiotriphosphate); In Vitro Techniques; Male; Mesenteric Arteries; Permeability; Phenylephrine; Rats; Rats, Sprague-Dawley; Sodium Fluoride; Vasoconstriction

2012